Viridian Therapeutics, Inc.\DE (VRDN)

Latest Insider Confidence Score

2026Q1

48.0
Bearish

Company insider confidence (by quarter)

2014Q2 2026Q1

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Booth Bruce Director 3,948,216 Feb 13, 2017
Fairmount Funds Management LLC Director 3,914,458 Oct 27, 2025
Fairmount Healthcare Fund II GP LLC Director 3,914,458 Oct 27, 2025
Fairmount Healthcare Fund II L.P. Director 3,914,458 Oct 27, 2025
Atlas Venture Fund VII L P — 3,142,580 Feb 13, 2017

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Mar 3, 2026 Mar 4, 2026 Tousignant Jennifer Chief Legal Officer Sell 22.5 -1,724 -33.35% ✗ $50.5K
Mar 3, 2026 Mar 4, 2026 Harmon Seth CFO Sell 22.5 -2,091 -21.16% ✗ $61.3K
Mar 4, 2026 Harmon Seth CFO Neutral 52.5 - 0.00% ✗ -
Mar 4, 2026 Tousignant Jennifer Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Mar 3, 2026 Mar 4, 2026 Beetham Thomas W. COO Sell 22.5 -3,138 -19.12% ✗ $92K
Mar 3, 2026 Mar 4, 2026 Mahoney Stephen F. CEO Sell 22.5 -7,627 -18.71% ✗ $223.6K
Mar 2, 2026 Mar 4, 2026 Tripuraneni Radhika Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Dec 31, 2025 Jan 2, 2026 Tousignant Jennifer Chief Legal Officer Sell 22.5 -2,272 -100.00% ✗ $70.8K
Oct 23, 2025 Oct 27, 2025 Fairmount Funds Management LLC Director Buy 100.0 +454,545 13.14% ✗ $10M
Jul 1, 2025 Jul 2, 2025 CAIN CHRISTOPHER W. Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 Jul 2, 2025 Kiselak Tomas Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 Jul 2, 2025 Morris Arlene Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 Jul 2, 2025 Ajer Jeffrey Robert Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 Jul 2, 2025 Gheuens Sarah Director Neutral 52.5 - 0.00% ✗ -
Jul 1, 2025 Jul 2, 2025 Moses Jennifer K. Director Neutral 52.5 - 0.00% ✗ -
Jun 9, 2025 Jun 11, 2025 Fairmount Funds Management LLC Director Neutral 52.5 - 0.00% ✗ -
Apr 7, 2025 Apr 9, 2025 Ajer Jeffrey Robert Director Neutral 52.5 - 0.00% ✗ -
Apr 9, 2025 Ajer Jeffrey Robert Director Neutral 52.5 - 0.00% ✗ -
Mar 10, 2025 Mar 12, 2025 Tripuraneni Radhika Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 12, 2025 Tripuraneni Radhika Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Mar 10, 2025 Mar 12, 2025 CAIN CHRISTOPHER W. Director Neutral 52.5 - 0.00% ✗ -
Mar 12, 2025 CAIN CHRISTOPHER W. Director Neutral 52.5 - 0.00% ✗ -
Mar 3, 2025 Mar 4, 2025 Tousignant Jennifer Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Mar 3, 2025 Mar 4, 2025 Mahoney Stephen F. CEO Neutral 52.5 - 0.00% ✗ -
Mar 3, 2025 Mar 4, 2025 Beetham Thomas W. COO Neutral 52.5 - 0.00% ✗ -
Mar 3, 2025 Mar 4, 2025 Harmon Seth CFO Neutral 52.5 - 0.00% ✗ -
Sep 27, 2024 Sep 30, 2024 Beetham Thomas W. COO Buy 95.0 +5,000 500.00% ✗ $117.1K
Sep 27, 2024 Sep 30, 2024 Mahoney Stephen F. CEO Buy 97.5 +21,400 100.00% ✗ $499.3K
Sep 13, 2024 Sep 17, 2024 Fairmount Funds Management LLC Director Buy 100.0 +1,600,000 86.68% ✗ $30M
Jun 26, 2024 Jun 28, 2024 Gheuens Sarah Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2024 Jun 28, 2024 Morris Arlene Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2024 Jun 28, 2024 Moses Jennifer K. Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2024 Jun 28, 2024 Harwin Peter Evan Director Neutral 52.5 - 0.00% ✗ -
Jun 26, 2024 Jun 28, 2024 Kiselak Tomas Director Neutral 52.5 - 0.00% ✗ -
Mar 28, 2024 Apr 1, 2024 Fairmount Funds Management LLC Director Neutral 52.5 - 0.00% ✗ -
Feb 14, 2024 Tousignant Jennifer Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Feb 12, 2024 Feb 14, 2024 Tousignant Jennifer Chief Legal Officer Neutral 52.5 - 0.00% ✗ -
Feb 5, 2024 Feb 7, 2024 Ciulla Thomas Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Jan 22, 2024 Jan 24, 2024 Fairmount Funds Management LLC Director Buy 100.0 +476,190 34.77% ✗ $10M
Jan 12, 2024 Ciulla Thomas Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Nov 10, 2023 Nov 13, 2023 Harmon Seth Officer Neutral 52.5 - 0.00% ✗ -
Oct 30, 2023 Nov 1, 2023 Fairmount Funds Management LLC Director Neutral 52.5 - 0.00% ✗ -
Nov 1, 2023 Beetham Thomas W. COO Neutral 52.5 - 0.00% ✗ -
Oct 30, 2023 Nov 1, 2023 Beetham Thomas W. COO Neutral 52.5 - 0.00% ✗ -
Oct 30, 2023 Nov 1, 2023 Mahoney Stephen F. CEO Neutral 52.5 - 0.00% ✗ -
Nov 1, 2023 Mahoney Stephen F. CEO Neutral 52.5 - 0.00% ✗ -
Sep 21, 2023 Sep 25, 2023 Gheuens Sarah Director Neutral 52.5 - 0.00% ✗ -
Sep 25, 2023 Gheuens Sarah Director Neutral 52.5 - 0.00% ✗ -
Sep 19, 2023 Harmon Seth Officer Neutral 52.5 - 0.00% ✗ -
Jun 15, 2023 Jun 20, 2023 Meisner Lara Chief Legal Officer Sell 37.5 -2,296 -3.69% ✓ $64.3K
Jun 14, 2023 Jun 16, 2023 Harwin Peter Evan Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Moses Jennifer K. Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Kiselak Tomas Director Neutral 52.5 - 0.00% ✗ -
Jun 14, 2023 Jun 16, 2023 Morris Arlene Director Neutral 52.5 - 0.00% ✗ -
Jun 2, 2023 Jun 6, 2023 Meisner Lara Chief Legal Officer Sell 28.8 -7,500 -7.70% ✓ $186.1K
Apr 12, 2023 Apr 12, 2023 Myers Scott Dunseth CEO Buy 82.5 +4,000 1.57% ✗ $101.5K
Mar 13, 2023 Mar 13, 2023 Myers Scott Dunseth CEO Buy 82.5 +5,500 2.20% ✗ $160.3K
Mar 9, 2023 Mar 10, 2023 Meisner Lara General Counsel and Secretary Sell 7.5 -29,971 -100.00% ✓ $871.3K
Feb 8, 2023 Feb 10, 2023 Katz Barrett Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 8, 2023 Feb 10, 2023 Melvin Carrie COO Neutral 52.5 - 0.00% ✗ -
Feb 8, 2023 Feb 10, 2023 Humer Kristian CFO Neutral 52.5 - 0.00% ✗ -
Feb 8, 2023 Feb 10, 2023 Meisner Lara General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Feb 6, 2023 Feb 7, 2023 Myers Scott Dunseth CEO Neutral 90.0 +250,000 100.00% ✗ -
Feb 7, 2023 Myers Scott Dunseth CEO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2023 Feb 7, 2023 Violin Jonathan CEO Sell 23.8 -50,000 -9.42% ✓ $1.8M
Feb 2, 2023 Feb 3, 2023 Violin Jonathan CEO Sell 20.0 -50,000 -10.40% ✓ $1.8M
Jan 23, 2023 Jan 25, 2023 Meisner Lara General Counsel and Secretary Sell 10.0 -6,843 -100.00% ✓ $244K
Jan 13, 2023 Jan 18, 2023 Katz Barrett Chief Medical Officer Sell 5.0 -29,000 -100.00% ✓ $1.1M
Jan 9, 2023 Jan 11, 2023 Katz Barrett Chief Medical Officer Sell 5.0 -60,000 -100.00% ✓ $2.1M
Dec 20, 2022 Dec 22, 2022 Meisner Lara General Counsel and Secretary Sell 7.5 -16,926 -100.00% ✓ $493.4K
Dec 15, 2022 Dec 19, 2022 Meisner Lara General Counsel and Secretary Sell 13.8 -1,597 -100.00% ✓ $45.3K
Dec 12, 2022 Dec 14, 2022 Meisner Lara General Counsel and Secretary Sell 7.5 -16,256 -100.00% ✓ $457.1K
Nov 15, 2022 Nov 16, 2022 Meisner Lara General Counsel and Secretary Sell 10.0 -8,125 -100.00% ✓ $179.2K
Aug 17, 2022 Aug 19, 2022 Fairmount Funds Management LLC Director Buy 100.0 +425,531 45.07% ✗ $10M
Jun 24, 2022 Melvin Carrie COO Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Moses Jennifer K. Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Kiselak Tomas Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Harwin Peter Evan Director Neutral 52.5 - 0.00% ✗ -
Jun 8, 2022 Jun 10, 2022 Morris Arlene Director Neutral 52.5 - 0.00% ✗ -
Jun 1, 2022 Jun 2, 2022 Violin Jonathan CEO Sell 30.0 -30,000 -5.87% ✓ $366K
May 2, 2022 May 4, 2022 Violin Jonathan CEO Sell 30.0 -30,000 -5.55% ✓ $391.2K
Apr 1, 2022 Apr 5, 2022 Violin Jonathan CEO Sell 30.0 -30,000 -5.25% ✓ $567.6K
Mar 1, 2022 Mar 3, 2022 Violin Jonathan CEO Sell 35.0 -30,000 -4.99% ✓ $529.5K
Feb 2, 2022 Feb 3, 2022 Humer Kristian CFO Neutral 52.5 - 0.00% ✗ -
Feb 2, 2022 Feb 3, 2022 Katz Barrett Chief Medical Officer Neutral 52.5 - 0.00% ✗ -
Feb 2, 2022 Feb 3, 2022 Meisner Lara General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Feb 1, 2022 Feb 3, 2022 Violin Jonathan CEO Sell 35.0 -30,000 -4.76% ✓ $572.8K
Dec 31, 2021 Jan 3, 2022 Humer Kristian CFO Neutral 52.5 - 0.00% ✗ -
Dec 8, 2021 Dec 10, 2021 Violin Jonathan Officer Neutral 52.5 - 0.00% ✗ -
Oct 4, 2021 Meisner Lara General Counsel and Secretary Neutral 52.5 - 0.00% ✗ -
Sep 23, 2021 Sep 28, 2021 Frazier Life Sciences Public Fund, L.P. 10% Owner Buy 100.0 +200,000 15.32% ✗ $2.2M
Sep 21, 2021 Sep 23, 2021 Fairmount Funds Management LLC Director Buy 100.0 +909,000 2590.33% ✗ $10M
Aug 26, 2021 Frazier Life Sciences Public Fund, L.P. 10% Owner Neutral 52.5 - 0.00% ✗ -
Jul 26, 2021 Jul 27, 2021 Humer Kristian CFO Neutral 52.5 - 0.00% ✗ -
Jul 27, 2021 Humer Kristian CFO Neutral 52.5 - 0.00% ✗ -
Jul 27, 2021 Humer Kristian CFO Neutral 52.5 - 0.00% ✗ -
Jul 14, 2021 Jul 15, 2021 Moses Jennifer K. Director Neutral 52.5 - 0.00% ✗ -
Jul 15, 2021 Moses Jennifer K. Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2021 Jun 16, 2021 Kiselak Tomas Director Neutral 52.5 - 0.00% ✗ -
Jun 3, 2021 Jun 16, 2021 Morris Arlene Director Neutral 52.5 - 0.00% ✗ -